Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.

[1]  Heinz Baumann,et al.  Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions. , 2016, Annals of the American Thoracic Society.

[2]  R. Graham,et al.  Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer. , 2014, The Journal of surgical research.

[3]  D. Flieder,et al.  Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue. , 2013, Oral oncology.

[4]  Clare Allen,et al.  TOOKAD® Soluble vascular‐targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer , 2013, BJU international.

[5]  Hiroshi Iseki,et al.  Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. , 2013, Journal of neurosurgery.

[6]  Ronald Sroka,et al.  Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL). , 2013, Urologic oncology.

[7]  J. Davison,et al.  Endotherapy for superficial adenocarcinoma of the esophagus: an American experience. , 2013, Gastrointestinal endoscopy.

[8]  D. Flieder,et al.  Dysplasia at the Margin? Investigating the Case for Subsequent Therapy in Squamous Cell Carcinoma of the Oral Tongue , 2012 .

[9]  Keith Cengel,et al.  Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. , 2012, The Annals of thoracic surgery.

[10]  T. Zhu,et al.  Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration. , 2010, Photodiagnosis and photodynamic therapy.

[11]  Tayyaba Hasan,et al.  Photobleaching‐based Dosimetry Predicts Deposited Dose in ALA‐PpIX PDT of Rodent Esophagus , 2007, Photochemistry and photobiology.

[12]  M. Biel.  Advances in photodynamic therapy for the treatment of head and neck cancers , 2006, Lasers in surgery and medicine.

[13]  T. Inokuchi,et al.  Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft. , 2006, Oral oncology.

[14]  L. Gossner,et al.  Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.

[15]  L. Lilge,et al.  Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[16]  C. R. Leemans,et al.  Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.

[17]  M. Lein,et al.  Photodynamic Therapy of Prostate Cancer by Means of 5-Aminolevulinic Acid-Induced Protoporphyrin IX – In vivo Experiments on the Dunning Rat Tumor Model , 2004, Urologia Internationalis.

[18]  H Stepp,et al.  Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. , 2001, The Journal of urology.

[19]  C. Hopper,et al.  Photodynamic therapy: a clinical reality in the treatment of cancer. , 2000, The Lancet. Oncology.

[20]  M. Biel.  Photodynamic therapy and the treatment of head and neck neoplasia , 1998, The Laryngoscope.

[21]  P. Speight,et al.  Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.

[22]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[23]  T. Okunaka,et al.  A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Speight,et al.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.

[25]  M F Mafee,et al.  Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. , 1990, Archives of otolaryngology--head & neck surgery.

[26]  B. Shumaker.  RE: Complications of whole bladder dihematoporphyrin ether photodynamic therapy. , 1990, The Journal of urology.

[27]  T. Wieman,et al.  Complications of whole bladder dihematoporphyrin ether photodynamic therapy. , 1989, The Journal of urology.

[28]  U. Nseyo,et al.  Photodynamic therapy for palliation of locally recurrent breast carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Biel,et al.  Photodynamic therapy of head and neck cancers. , 2010, Methods in molecular biology.

[30]  Henry Hirschberg,et al.  Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. , 2006, Journal of neurosurgery.

[31]  D I Rosenthal,et al.  Photodynamic Therapy in the Treatment of Cancer , 1999, Drugs.